Inventiva Management

Management criteria checks 4/4

Inventiva's CEO is Frederic Cren, appointed in Jan 2011, has a tenure of 12.58 years. total yearly compensation is €877.74K, comprised of 34.2% salary and 65.8% bonuses, including company stock and options. directly owns 13.37% of the company’s shares, worth €21.07M. The average tenure of the management team and the board of directors is 6.9 years and 6.5 years respectively.

Key information

Frederic Cren

Chief executive officer

€877.7k

Total compensation

CEO salary percentage34.2%
CEO tenure12.6yrs
CEO ownership13.4%
Management average tenure6.9yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Frederic Cren's remuneration changed compared to Inventiva's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022€878k€300k

-€54m

Sep 30 2022n/an/a

-€55m

Jun 30 2022n/an/a

-€56m

Mar 31 2022n/an/a

-€56m

Dec 31 2021€929k€299k

-€50m

Sep 30 2021n/an/a

-€45m

Jun 30 2021n/an/a

-€41m

Mar 31 2021n/an/a

-€36m

Dec 31 2020€388k€267k

-€34m

Sep 30 2020n/an/a

-€29m

Jun 30 2020n/an/a

-€25m

Mar 31 2020n/an/a

-€27m

Dec 31 2019€374k€243k

-€30m

Sep 30 2019n/an/a

-€34m

Jun 30 2019n/an/a

-€37m

Mar 31 2019n/an/a

-€35m

Dec 31 2018€376k€243k

-€33m

Sep 30 2018n/an/a

-€29m

Jun 30 2018n/an/a

-€25m

Mar 31 2018n/an/a

-€22m

Dec 31 2017€372k€243k

-€19m

Sep 30 2017n/an/a

-€16m

Jun 30 2017n/an/a

-€13m

Mar 31 2017n/an/a

-€10m

Dec 31 2016€365k€243k

-€7m

Compensation vs Market: Frederic's total compensation ($USD962.65K) is about average for companies of similar size in the UK market ($USD745.84K).

Compensation vs Earnings: Frederic's compensation has been consistent with company performance over the past year.


CEO

Frederic Cren (57 yo)

12.6yrs

Tenure

€877,744

Compensation

Mr. Frederic Cren has been Chief Executive Officer of Inventiva S.A. since co-founding Inventiva S.A. in 2011. Mr. Cren has been Chairman at Inventiva S.A. since May 31, 2016. He served as President of Inv...


Leadership Team

NamePositionTenureCompensationOwnership
Frederic Cren
Co-Founder12.6yrs€877.74k13.37%
€ 21.1m
Pierre Broqua
Co-Founder12.6yrs€751.66k9.25%
€ 14.6m
Jean Volatier
Chief Financial Officer11yrsno data0.32%
€ 506.2k
Alice Roudot-Ketelers
Chief Operating Officerless than a yearno datano data
Eric Duranson
General Counsel2.1yrsno datano data
Nathalie Harroy
Head of Human Resources11.6yrsno data0.11%
€ 171.6k
Irena Konstantinova
Head of Biology & Pharmacologyno datano datano data
Michael Cooreman
Chief Medical Officer2.8yrsno datano data
Jean-Paul Dutertre
Head of Pharmacovigilance1.9yrsno datano data

6.9yrs

Average Tenure

57.5yo

Average Age

Experienced Management: IVAP's management team is seasoned and experienced (6.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frederic Cren
Co-Founder7.3yrs€877.74k13.37%
€ 21.1m
Pierre Broqua
Co-Founder7.3yrs€751.66k9.25%
€ 14.6m
Chris Buyse
Independent Director6.5yrs€61.20k0%
€ 0
Annick Schwebig
Independent Director6.5yrs€61.20k0.0073%
€ 11.6k
Jean-Louis Junien
Chairman of Scientific Advisory Boardno data€16.00kno data
Xiaoqin Lu
Independent Director5.3yrs€43.20kno data
Heinz Maeusli
Independent Director4.3yrs€49.20kno data
Sven Francque
Member of Scientific Advisory Boardno datano datano data
Manal Abdelmalek
Member of Scientific Advisory Boardno datano datano data
Kenneth Cusi
Member of Scientific Advisory Boardno datano datano data
Glen Clack
Member of Scientific Advisory Boardno datano datano data
Gérard Zalcman
Scientific Advisory Board Memberno datano datano data

6.5yrs

Average Tenure

60yo

Average Age

Experienced Board: IVAP's board of directors are considered experienced (6.5 years average tenure).